It happens when ambitious biotech founders, forward-thinking investors, pharmaceutical leaders and experienced clinical development experts come together.
THE NEXT MILESTONE is a new, invitation-only gathering designed to connect the people financing biotech innovation with those bringing it closer to patients.
Securing investment is only one part of the journey. Turning that investment into meaningful clinical progress requires the right expertise, decisions and partnerships.
THE NEXT MILESTONE creates a space for the conversations that matter most.
Explore what makes emerging biotech companies attractive to investors and how clinical milestones influence long-term value.
Connect with leaders who understand the challenges of building, financing and advancing innovative therapies.
Meet people you might not otherwise encounter, in an intimate setting designed for genuine dialogue.
A curated gathering of biotech innovators, investors, pharmaceutical leaders and clinical development experts.
One afternoon of meaningful conversations about the capital, partnerships and decisions that move breakthrough therapies forward.
Entrepreneurs and leaders building the next generation of therapeutic innovations.
Investors backing promising science and the teams bringing it forward.
Business development & licensing, external innovation, search & evaluation, R&D strategy and clinical leaders scouting their next partnership.
Experts who turn promising opportunities into executable development programs.
Organizations helping biotech companies grow, connect and succeed.
An afternoon of fresh perspectives and candid conversations, followed by an evening dedicated to building meaningful relationships.
All in one of Europe's most dynamic life-sciences hubs. Barcelona, 4 February 2027.
Venue details will be announced.
An afternoon bringing together biotech innovators, investors, pharmaceutical leaders and clinical development experts to explore the decisions that turn scientific breakthroughs into clinical and commercial progress.
What makes a biotech investable, and what are investors really looking for?
Navigating first-in-human development, clinical evidence and the opportunities presented by AI.
How to turn promising data into the next investment, strategic partnership or development opportunity.
Communicating biotech innovation in a way that captures investors' and pharma partners' attention.
An honest conversation about investment decisions, access to capital and women-led biotech innovation.
Biotech, pharma and investors are invited personally. Service providers can apply for a limited number of passes, so the room stays balanced.
For biotech founders and executives, mid-sized and large pharma, venture capital and investors, and selected ecosystem partners.
For CROs, CDMOs, clinical technology companies and other R&D service providers. Includes access to all afternoon sessions, networking breaks, and the evening drinks, tapas & networking.
An optional morning masterclass (10:00–12:30) for biotech founders on communicating their value to investors and to pharma licensing and partnering teams.
Industry Partner Passes are subject to approval to maintain a balanced audience. A pass covers attendance and networking; speaking opportunities and visibility are available through partnerships.
We're inviting a select group of organizations to help bring THE NEXT MILESTONE to life.
Partnership offers an opportunity to connect with an influential biotech and investment community, demonstrate expertise and support the next generation of life-sciences innovation.
Founding partnerships, event partnerships and ecosystem collaborations are available for discussion.
Explore partnership opportunities→THE NEXT MILESTONE is being developed as a European series of intimate, high-impact gatherings, connecting local biotech ecosystems with the capital, expertise and relationships needed to move innovation forward.
With nearly three decades of international experience across clinical research, biotech and pharma, Catherine has built her career connecting people, organizations and opportunities.
She founded THE NEXT MILESTONE on a simple belief:
The right connections can accelerate the journey from scientific innovation to patient impact.
Whether you're building a biotech company, investing in innovation or helping advance clinical development, we'd love to hear from you.
Participation is subject to confirmation. Registration of interest does not guarantee an invitation.
{{ doneText }}